Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-739-4
CAS number: 149-44-0
Basic toxicokinetics are derived from secondary literature that does not meet the criteria of today standards. Absorption:oral uptake: Very slow resorption from the digestive tract. Possible in the case of inhaling substance dust.dermal exposure: Any relevant dermal absorption is not expected.inhalation: Uptake by inhalation may be relevant after exposure to dusts; due to the particle size distribution only a very limited fraction may pass the tracheal airways down to the alveoli. Most of the substance will be dissolved in water based body fluids, e.g. salivary fluid.Distribution: Due to the strong hydrophilicity, a fast distribution after systemic absorption into blood, plasma and further water based body fluids is to be expected. A transfer to any lipophilic compartments of the human body is highly unlikely.Skin: No indication of an increase of skin problems caused by exposure (corrosion, irritation, allergic skin sensitization).Respiratory tract, pulmonary function:Neither reductions of the pulmonary function appeared nor any indication for an inhalative sensitization due to the inhalation of product dust was given. CMR, target-organic toxicityNo indication of a development of malignant neoplasia was observed. No indication of specific target-organic toxicity could be determined. This also applies for effects on the respiratory tract and the mucous membranes.Excretion: Excretion of (unchanged) substance from the body is fast and obviously does not need any metabolic conversion due to its high water solubility.
substance shows no bioaccumulation potential. After intravenous
injection in dogs most of it disappeared from the blood in less than 2
hours and practically all disappeared within 5 hours.
unlikely (due to ionic structure)
possible (inhaling of dust)
unlikely (due to particle size and solubility)
distribution into blood, plasma and further water based body fluids.
Transfer to any lipophilic compartments is highly unlikely.
were not identified in the experiments with dogs (see above), but most
of the substance was excreted renally (up to 68 % within 8 hours after
intravenous application). An oxidation of the sulphur containing part of
the substance to sulphate may be possible.
is fast and obviously does not need any metabolic conversion due to its
high water solubility.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
På den här webbplatsen används kakor. Syftet är att optimera din upplevelse av den.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again